There's a dog doping scandal brewing in the Iditarod race

Iditarod sled dogs.
(Image credit: JIM WATSON/AFP/Getty Images)

There is controversy brewing in the last frontier. One of the top 20 finishers in the 2017 Iditarod Trail Sled Dog Race possibly gave their team the banned opioid pain reliever Tramadol, Alaska Dispatch News reports. It is the first time dogs have tested positive for an illegal substance in the history of the nearly 1,000-mile race.

While the president of the Iditarod Officials Finishers Club, Wade Marrs, did not name the musher in question (he or she is referred to only as "Musher X"), the positive test for Tramadol was reportedly isolated to a single top-finishing dog team.

"Race officials have refused to provide the musher's name, citing 'legal concerns,' the Dispatch News writes. "They have said they cannot prove the musher's intent, so they cannot penalize the musher under the 2017 race rules, which they have since revised." Musher X denied administering the drug and "repeatedly offered to submit to a polygraph and complied fully with all requests," Marrs' statement said.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

"It's not a good situation," Iditarod Board member Aaron Burmeister told The Associated Press. "I'm hoping that we can turn a positive light on it and the musher steps forward."

To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us